Tiagabine Hydrochloride Tablet
Product Images NDC 72205-086

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tiagabine Hydrochloride (NDC 72205-086). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12mg-30s-cntr-label (12mg 30s Cntr Label)

Tiagabine Hydrochloride 12 mg tablets label for oral use. The label indicates a package count of 30 tablets and includes instructions for pharmacists to dispense the accompanying Medication Guide. Manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Additional storage and handling information is provided alongside a barcode.*

FDA Label Image

16mg-30s-cntr-label (16mg 30s Cntr Label)

Label for Tiagabine Hydrochloride Tablets, 16 mg strength, containing 30 tablets. The label includes the National Drug Code (NDC) 72205-087-30 and states the product is prescription only (Rx Only). Manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. The label features storage instructions and a pharmacist advisory to dispense the medication guide.*

FDA Label Image

2mg-30s-cntr-label (2mg 30s Cntr Label)

Label for Tiagabine Hydrochloride Tablets, 2 mg strength, containing 30 tablets. The label includes directions to dispense a medication guide to patients, storage instructions, manufacturer details (MSN Laboratories Private Limited, India), and distributor information (Novadoz Pharmaceuticals LLC, Piscataway, NJ). The label features a barcode and the NDC number 72205-084-30.*

FDA Label Image

4mg-30s-cntr-label (4mg 30s Cntr Label)

Label for Tiagabine Hydrochloride Tablets 4 mg, oral dosage form. The label indicates a package of 30 tablets, NDC 72205-085-30, manufactured by MSN Laboratories Private Limited and distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions, a pharmacist note to dispense a medication guide, and barcode information.*

FDA Label Image

Fig-1 (Tiagabine Fig 1)

A line graph titled Figure 1, Study 1, comparing percentage reduction in partial seizure rate between Tiagabine Hydrochloride 32 + 56 mg/day and placebo groups. The y-axis shows % reduction in seizure rate (ranging from -250% to 100%), and the x-axis shows % of patients (from 100 to 0). Two lines represent Tiagabine Hydrochloride (solid) and placebo (dotted), indicating differing patient response distributions, with an improvement-worsening scale on the right.*

FDA Label Image

Fig-2 (Tiagabine Fig 2)

A cumulative distribution plot from Study 1 showing the percentage reduction in partial seizure rate versus the percentage of patients. It compares Placebo and Tiagabine Hydrochloride doses of 16 mg/day, 32 mg/day, and 56 mg/day, with improvement indicated upward and worsening downward on the vertical axis.*

FDA Label Image

Fig-3 (Tiagabine Fig 3)

A cumulative distribution plot from Study 2 illustrating the percentage reduction in partial seizure rate for patients. The x-axis shows the percentage of patients, while the y-axis shows percentage reduction in partial seizure rate, ranging from worsening to improvement. Three treatment groups are compared: placebo (dotted line), Tiagabine Hydrochloride 8 mg QID (dashed line), and Tiagabine Hydrochloride 16 mg BID (solid line).*

FDA Label Image

Fig-4 (Tiagabine Fig 4)

A line chart labeled Figure 4 from Study 3 showing the percentage reduction in partial seizure rate on the y-axis against the percentage of patients on the x-axis. Two curves represent placebo (dashed line) and Tiagabine Hydrochloride 10 mg TID (solid line), indicating patient responses ranging from worsening to improvement in seizure rate.*

FDA Label Image

Tia-str (Tiagabine Structure)

Chemical structure of Tiagabine Hydrochloride, showing its molecular components and arrangement, including thiophene rings, a piperidine ring, and a carboxylic acid group associated with hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.